Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3523276011 | Product containing betamethasone and salicylic acid (medicinal product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3713526010 | Betamethasone- and salicylic acid-containing product | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 50013801000188114 | médicament contenant bétaméthasone et acide salicylique | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Common French translation module (core metadata concept) |
| 608321000241115 | médicament contenant bétaméthasone et acide salicylique (produit médicinal) | fr | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Common French translation module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing betamethasone and salicylic acid (medicinal product) | Plays role | Antifungal therapeutic role (role) | true | Inferred relationship | Some | ||
| Product containing betamethasone and salicylic acid (medicinal product) | est un(e) (attribut) | Product containing betamethasone in topical dosage form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing betamethasone and salicylic acid (medicinal product) | a pour principe actif (attribut) | Betamethasone | true | Inferred relationship | Some | 1 | |
| Product containing betamethasone and salicylic acid (medicinal product) | a pour principe actif (attribut) | Adrenal hormone | false | Inferred relationship | Some | ||
| Product containing betamethasone and salicylic acid (medicinal product) | a pour principe actif (attribut) | Corticosterone | false | Inferred relationship | Some | ||
| Product containing betamethasone and salicylic acid (medicinal product) | a pour principe actif (attribut) | Adrenal hormone agent (substance) | false | Inferred relationship | Some | ||
| Product containing betamethasone and salicylic acid (medicinal product) | est un(e) (attribut) | acide salicylique | true | Inferred relationship | Some | ||
| Product containing betamethasone and salicylic acid (medicinal product) | a pour principe actif (attribut) | Keratolytic agent (substance) | false | Inferred relationship | Some | ||
| Product containing betamethasone and salicylic acid (medicinal product) | a pour principe actif (attribut) | Salicylic acid (substance) | true | Inferred relationship | Some | 2 | |
| Product containing betamethasone and salicylic acid (medicinal product) | a pour principe actif (attribut) | Glucocorticoid hormone | false | Inferred relationship | Some | ||
| Product containing betamethasone and salicylic acid (medicinal product) | a pour principe actif (attribut) | Topical agent (substance) | false | Inferred relationship | Some | ||
| Product containing betamethasone and salicylic acid (medicinal product) | a une forme pharmaceutique (attribut) | Cutaneous AND/OR transdermal dosage form | false | Inferred relationship | Some | ||
| Product containing betamethasone and salicylic acid (medicinal product) | est un(e) (attribut) | Product containing betamethasone (medicinal product) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing betamethasone and salicylic acid in cutaneous dose form (medicinal product form) | est un(e) (attribut) | True | Product containing betamethasone and salicylic acid (medicinal product) | Inferred relationship | Some | |
| Betamethasone and salicylic acid only product | est un(e) (attribut) | True | Product containing betamethasone and salicylic acid (medicinal product) | Inferred relationship | Some | |
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment | est un(e) (attribut) | False | Product containing betamethasone and salicylic acid (medicinal product) | Inferred relationship | Some | |
| Betamethasone+salicylic acid 0.05/3% scalp application (product) | est un(e) (attribut) | False | Product containing betamethasone and salicylic acid (medicinal product) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR